ANI Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 5, 2026 at 8:00 a.m. ETGlobeNewsWire · 1 day ago
ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release CapsulesGlobeNewsWire · 5 days ago
ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $388,206.00 in StockDefense World · 5 days ago
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research · Oct 13, 2026
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarZacks Investment Research · Oct 13, 2026
Head to Head Comparison: ANI Pharmaceuticals (NASDAQ:ANIP) and Talphera (NASDAQ:TLPH)Defense World · Oct 6, 2026ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 7, 2026 | $2.04 | $2.21 | Beat |
| May 8, 2026 | $1.28 | $2.05 | Beat |
| Feb 27, 2026 | $1.99 | $2.33 | Beat |
| Nov 7, 2025 | $1.74 | $2.04 | Beat |
| Aug 8, 2025 | $1.38 | $1.80 | Beat |
| May 9, 2025 | $1.37 | $1.70 | Beat |